Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
VRDN
#3856
Viridian Therapeutics, Inc. Common Stock
29.380
0
+2.98%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+2.98%
Monthly Change
-12.59%
6 month change
+30.87%
Year Change
+30.87%
Previous Close
28.530
0
Open
29.380
0
Bid
Ask
Low
29.380
0
High
29.380
0
Volume
105
Markets
US Stock Market
Healthcare
VRDN
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
News
Stifel reiterates Viridian Therapeutic stock rating on BLA review
Jefferies raises Viridian Therapeutic stock price target on trial progress
Evercore ISI reiterates Viridian Therapeutic stock rating on data conviction
Viridian Therapeutics, Inc. (VRDN) Reports Q4 Loss, Misses Revenue Estimates
Viridian Therapeutics earnings missed by $0.10, revenue fell short of estimates
MiMedx (MDXG) Q4 Earnings and Revenues Beat Estimates
Truist reiterates Viridian Therapeutic stock rating ahead of trial
Evercore ISI raises Viridian Therapeutics stock price target on subQ TED potential
Viridian Therapeutics: Cautious Optimism As Key Milestones Approach (Downgrade) (VRDN)
Viridian Therapeutics stock hits 52-week high at $34.06
UBS initiates Viridian Therapeutic stock with Buy rating on TED treatment
Viridian Therapeutic stock a Top Pick at TD Cowen ahead of busy 2026